EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases

Zeeshan Sattar iD, Alnardo Lora iD, Bakr Jundi iD, Christopher Railwah iD, Patrick Geraghty iD

Pulmonary Medicine · 18.06.2021 · 2021 · 1-20

DOI: 10.1155/2021/5488591 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pulmonary Medicine, erschienen am 18.06.2021. Verfasst von Zeeshan Sattar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, 450 Clar…. Hauptthemen laut MEDLINE: Lung Diseases, S100 Proteins. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alpha-1 Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The S100 protein family consists of over 20 members in humans that are involved in many intracellular and extracellular processes, including proliferation, differentiation, apoptosis, Ca2+ homeostasis, energy metabolism, inflammation, tissue repair, and migration/invasion. Although there are structural similarities between each member, they are not functionally interchangeable. The S100 proteins function both as intracellular Ca2+ sensors and as extracellular factors. Dysregulated responses of multiple members of the S100 family are observed in several diseases, including the lungs (asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, cystic fibrosis, pulmonary hypertension, and lung cancer). To this degree, extensive research was undertaken to identify their roles in pulmonary disease pathogenesis and the identification of inhibitors for several S100 family members that have progressed to clinical trials in patients for nonpulmonary conditions. This review outlines the potential role of each S100 protein in pulmonary diseases, details the possible mechanisms observed in diseases, and outlines potential therapeutic strategies for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung DiseasesS100 ProteinsBiomarkersCalciumDrug DevelopmentHomeostasisHumansInflammationNeutrophils

Substanzen

BiomarkersS100 ProteinsCalcium

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
  • Department of Cell Biology, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.

ORCID-Profile: Zeeshan Sattar, Alnardo Lora, Bakr Jundi, Christopher Railwah, Patrick Geraghty

Förderung

  • Alpha-1 Foundation

Zitieren

APA

Sattar, Z., Lora, A., Jundi, B., Railwah, C., & Geraghty, P. (2021). The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases. Pulmonary Medicine, 2021, 1-20. https://doi.org/10.1155/2021/5488591

Vancouver

Sattar Z, Lora A, Jundi B, Railwah C, Geraghty P. The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases. Pulmonary Medicine. 2021;2021:1-20. doi:10.1155/2021/5488591

BibTeX
@article{Sattar2021,
  author = {Sattar, Zeeshan and Lora, Alnardo and Jundi, Bakr and Railwah, Christopher and Geraghty, Patrick},
  title = {The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases},
  journal = {Pulmonary Medicine},
  year = {2021},
  volume = {2021},
  pages = {1--20},
  doi = {10.1155/2021/5488591}
}
Kostenlos starten →